Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission

Neuropsychopharmacology

Volumn 33, Issue 8, 2008, Pages 1929-1941

  Ebner, Karl ^a   Singewald, Georg M ^a   Whittle, Nigel ^a   Ferraguti, Francesco ^b   Singewald, Nicolas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

5 Hydroxytryptamine; Lateral septum; Microdialysis; Neurokinin 1 receptor; Stress; Substance P

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; L 822429; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [[2 CYCLOPROPOXY 5 (5 TRIFLUOROMETHYL)TETRAZOL 1 YL]BENZYL] (2 PHENYLPIPERIDIN 3 YL)AMINE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SEROTONIN; SEROTONIN 1 RECEPTOR; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ELECTRON MICROSCOPY; FORCED SWIMMING TEST; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SEPTUM PELLUCIDUM; SEROTONINERGIC SYSTEM; STRESS MANAGEMENT;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; BEHAVIOR, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MICRODIALYSIS; MICROSCOPY, ELECTRON; NEURONS, AFFERENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, NEUROKININ-1; SEPTUM OF BRAIN; SEROTONIN; STEREOISOMERISM; STRESS, PSYCHOLOGICAL; SUBSTANCE P; SWIMMING; SYNAPTIC TRANSMISSION;

EID: 45149100927     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301594     Document Type: Article

References (80)

1. Adell A (2004). Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms? Curr Drug Targets CNS Neurol Disord 3: 113-121.
2. Bilkei-Gorzo A, Racz I, Michel K, Zimmer A (2002). Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. J Neurosci 22: 10046-10052.
3. Blier P, Gobbi G, Haddjeri N, Santarelli L, Mathew G, Hen R (2004). Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. J Psychiatry Neurosci 29: 208-218.
4. Bondi CO, Barrera G, Lapiz MD, Bedard T, Mahan A, Morilak DA (2007). Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Prog Neuropsychopharmacol Biol Psychiatry 31: 482-495.
5. Burgdorf J, Panksepp J (2006). The neurobiology of positive emotions. Neurosci Biobehav Rev 30: 173-187.
6. Chen LW, Wei LC, Liu HL, Qiu Y, Chan YS (2001). Cholinergic neurons expressing substance P receptor (NK(1)) in the basal forebrain of the rat: a double immunocytochemical study. Brain Res 904: 161-166.
7. Chenu F, Guiard BP, Bourin M, Gardier AM (2006). Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behav Brain Res 172: 256-263.
8. Conley RK, Cumberbatch MJ, Mason GS, Williamson DJ, Harrison T, Locker K et al (2002). Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity. J Neurosci 22: 7730-7736.
9. Corti C, Aldegheri L, Somogyi P, Ferraguti F (2002). Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. Neuroscience 110: 403-420.
10. Cryan JF, Valentino RJ, Lucki I (2005). Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29: 547-569.
11. Culman J, Unger T (1995). Central tachykinins: mediators of defence reaction and stress reactions. Can J Physiol Pharmacol 73: 885-891.
12. Dableh LJ, Yashpal K, Rochford J, Henry JL (2005). Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat. Eur J Pharmacol 507: 99-105.
13. David DJ, Froger N, Guiard B, Przybylski C, Jego G, Boni C et al (2004). Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice. Eur J Pharmacol 492: 41-48.
14. De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR (2004). 5-HT1A receptors are differentially involved in the anxiolytic-and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur Neuropsychopharmacol 14: 487-495.
15. Doutrelant O, Poulain P, Carette B (1993). Comparative distribution of calbindin and Met-enkephalin immunoreactivities in the guinea-pig lateral septum, with reference to electrophysiologically characterized neurons in the mediolateral part. Brain Res 615: 335-341.
16. Ebner K, Rupniak NM, Saria A, Singewald N (2004). Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci USA 101: 4280-4285.
17. Ebner K, Singewald N (2006). The role of substance P in stress and anxiety responses. Amino Acids 31: 251-272.
18. Ferraguti F, Cobden P, Pollard M, Cope D, Shigemoto R, Watanabe M et al (2004). Immunolocalization of metabotropic glutamate receptor 1alpha (mGluR1alpha) in distinct classes of interneuron in the CA1 region of the rat hippocampus. Hippocampus 14: 193-215.
19. Froger N, Gardier AM, Moratalla R, Alberti I, Lena I, Boni C et al (2001). 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J Neurosci 21: 8188-8197.
20. Furmark T, Appel L, Michelgard A, Wahlstedt K, Ahs F, Zancan S et al (2005). Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry 58: 132-142.
21. Gall C, Moore RY (1984). Distribution of enkephalin, substance P, tyrosine hydroxylase, and 5-hydroxytryptamine immunoreactivity in the septal region of the rat. J Comp Neurol 225: 212-227.
22. Gavioli EC, Canteras NS, De Lima TC (1999). Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus. NeuroReport 10: 3399-3403.
23. Gavioli EC, Canteras NS, De Lima TC (2002). The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebroventricular injection of substance P. Behav Brain Res 134: 411-415.
24. Gobbi G, Blier P (2005). Effect of neurokinin-1 receptor antagonists on serotonergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs. Peptides 26: 1383-1393.
25. Guiard BP, Froger N, Hamon M, Gardier AM, Lanfumey L (2005). Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice. J Neurochem 95: 1713-1723.
26. Guiard BP, Lanfumey L, Gardier AM (2006). Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review. Curr Drug Targets 7: 187-201.
27. Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C et al (2004). Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice. J Neurochem 89: 54-63.
28. Gustafson EL, Durkin MM, Bard JA, Zgombick J, Branchek TA (1996). A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain. Br J Pharmacol 117: 657-666.
29. Heinrichs SC, Menzaghi F, Pich EM, Baldwin HA, Rassnick S, Britton KT et al (1994). Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology 11: 179-186.
30. Herpfer I, Lieb K (2005). Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs 19: 275-293.
31. Hökfelt T, Kuteeva E, Stanic D, Ljungdahl A (2004). The histochemistry of tachykinin systems in the brain. In: Holzer P (ed). Tachykinins. Springer: Heidelberg. pp 63-120.
32. Hökfelt T, Pernow B, Wahren J (2001). Substance P: a pioneer amongst neuropeptides. J Intern Med 249: 27-40.
33. Keller M, Montgomery S, Ball W, Morrison M, Snavely D, Liu G et al (2005). Lack of efficacy of the substance P (neurokinin 1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry 59: 216-223.
34. Kirby LG, Allen AR, Lucki I (1995). Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 682: 189-196.
35. Kirby LG, Lucki I (1997). Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. J Pharmacol Exp Ther 282: 967-976.
36. Kirby LG, Lucki I (1998). The effect of repeated exposure to forced swimming on extracellular levels of 5-hydroxytryptamine in the rat. Stress 2: 251-263.
37. Köhler C, Chan-Palay V, Steinbusch H (1982). The distribution and origin of serotonin-containing fibers in the septal area: a combined immunohistochemical and fluorescent retrograde tracing study in the rat. J Comp Neurol 209: 91-111.
38. Korte SM, De Boer SF (2003). A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 463: 163-175.
39. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ et al (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640-1645.
40. Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D et al (2004). Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology 29: 385-392.
41. Landgraf R, Wotjak CT, Neumann ID, Engelmann M (1998). Release of vasopressin within the brain contributes to neuroendocrine and behavioral regulation. Progress Brain Res 119: 210-219.
42. Lanfumey L, Hamon M (2000). Central 5-HT1A receptors: regional distribution and functional characteristics. Nucl Med Biol 27: 429-435.
43. Lejeune F, Gobert A, Millan MJ (2002). The selective neurokinin (NK1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study. Brain Res 935: 134-139.
44. Lejeune F, Gobert A, Millan MJ (2003). The neurokinin (NK1) antagonist, GR205,171, alters the influence of serotonin (5-HT) reuptake inhibitors (SSRI) on serotonergic neurones: a dual electrophysiological and dialysis analysis. Soc Neurosci Abstr 889: 22.
45. Lieb K, Fiebich BL, Herpfer I, Mantovani M, Loffler M, Feuerstein TJ (2005). No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes. Eur Neuropsychopharmacol 15: 641-646.
46. Ljungdahl A, Hökfelt T, Nilsson G (1978). Distribution of substance P-like immunoreactivity in the central nervous system of the rat - I. Cell bodies and nerve terminals. Neuroscience 3: 861-943.
47. Malcangio M, Bowery NG (1999). Peptide autoreceptors: does an autoreceptor for substance P exist? Trends Pharmacol Sci 20: 405-407.
48. Martin P, Beninger RJ, Hamon M, Puech AJ (1990). Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Behav Brain Res 38: 135-144.
49. Maubach KA, Martin K, Smith DW, Hewson L, Frankshun RA, Harrison T et al (2001). Substance P stimulates inhibitory synaptic transmission in the guinea pig basolateral amygdala in vitro. Neuropharmacology 40: 806-817.
50. McLean S (2005). Do substance P and the NK1 receptor have a role in depression and anxiety? Curr Pharm Des 11: 1529-1547.
51. Millan MJ (2006). Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110: 135-370.
52. Millan MJ, Lejeune F, De Nanteuil G, Gobert A (2001). Selective blockade of neurokinin (NK1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats. J Neurochem 76: 1949-1954.
53. Misgeld U, Bijak M, Jarolimek W (1995). A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol 46: 423-462.
54. Morales M, Battenberg E, Bloom FE (1998). Distribution of neurons expressing immunoreactivity for the 5HT3 receptor subtype in the rat brain and spinal cord. J Comp Neurol 402: 385-401.
55. Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N (1994). Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol 347: 249-274.
56. O'Neill MF, Conway MW (2001). Role of 5-HT(1A) and 5-HT(1B) receptors in the mediation of behavior in the forced swim test in mice. Neuropsychopharmacology 24: 391-398.
57. Otsuka M, Yoshioka K (1993). Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73: 229-308.
58. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego.
59. Pazos A, Cortes R, Palacios JM (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346: 231-249.
60. Pazos A, Palacios JM (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346: 205-230.
61. Pompeiano M, Palacios JM, Mengod G (1992). Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12: 440-453.
62. Porsolt RD, Le Pichon M, Jalfre M (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266: 730-732.
63. Ronan PJ, Steciuk M, Kramer GL, Kram M, Petty F (2000). Increased septal 5-HIAA efflux in rats that do not develop learned helplessness after inescapable stress. J Neurosci Res 61: 101-106.
64. Rupniak NM (2002). New insights into the antidepressant actions of substance P (NK1 receptor) antagonists. Can J Physiol Pharmacol 80: 489-494.
65. Rupniak NM, Carlson EJ, Webb JK, Harrison T, Porsolt RD, Roux S et al (2001). Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behav Pharmacol 12: 497-508.
66. Saffroy M, Torrens Y, Glowinski J, Beaujouan JC (2003). Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience 116: 761-773.
67. Sakanaka M, Shiosaka S, Takatsuki K, Inagaki S, Hara Y, Kawai Y et al (1982). Origins of substance P-containing fibers in the lateral septal area of young rats: immunohistochemical analysis of experimental manipulations. J Comp Neurol 212: 268-277.
68. Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R et al (2001). Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98: 1912-1917.
69. Schreiber R, De Vry J (1993). Neuroanatomical basis for the antidepressant-like effects of the 5-HT1A receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav Pharmacol 4: 625-636.
70. Sekizawa S, Joad JP, Bonham AC (2003). Substance P presynaptically depresses the transmission of sensory input to bronchopulmonary neurons in the guinea pig nucleus tractus solitarii. J Physiol 552: 547-559.
71. Sheehan TP, Chambers RA, Russell DS (2004). Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Brain Res Rev 46: 71-117.
72. Sherman AD, Petty F (1982). Additivity of neurochemical changes in learned helplessness and imipramine. Behav Neural Biol 35: 344-353.
73. Singewald N, Kaehler S, Hemeida R, Philippu A (1997). Release of serotonin in the rat locus coeruleus: effects of cardiovascular, stressful and noxious stimuli. Eur J Neurosci 9: 556-562.
74. Singewald N, Chicchi GG, Thurner C, Tsao K-L, Schmidhammer H, Singewald GM et al (2007). Modulation of basal and stress-induced amygdaloid substance P release by the selective NK1 receptor antagonist L-822429. J Neurochem (submitted).
75. Szeidemann Z, Jakab RL, Shanabrough M, Leranth C (1995). Extrinsic and intrinsic substance P innervation of the rat lateral septal area calbindin cells. Neuroscience 69: 1205-1221.
76. Takayama H, Ota Z, Ogawa N (1986). Effect of immobilization stress on neuropeptides and their receptors in rat central nervous system. Regul Pept 15: 239-248.
77. Vertes RP (1991). A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313: 643-668.
78. Waeber C, Sebben M, Nieoullon A, Bockaert J, Dumuis A (1994). Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology 33: 527-541.
79. Waselus M, Galvez JP, Valentino RJ, Van Bockstaele EJ (2006). Differential projections of dorsal raphe nucleus neurons to the lateral septum and striatum. J Chem Neuroanat 31: 233-242.
80. Zocchi A, Varnier G, Arban R, Griffante C, Zanetti L, Bettelini L et al (2003). Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse. Neurosci Lett 345: 73-76.